BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 32731428)

  • 1. Layer-By-Layer Nanocoating of Antiviral Polysaccharides on Surfaces to Prevent Coronavirus Infections.
    Otto DP; de Villiers MM
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32731428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application prospect of polysaccharides in the development of anti-novel coronavirus drugs and vaccines.
    Chen X; Han W; Wang G; Zhao X
    Int J Biol Macromol; 2020 Dec; 164():331-343. PubMed ID: 32679328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future].
    Ye ZW; Jin DY
    Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):571-592. PubMed ID: 32347053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory activities of marine sulfated polysaccharides against SARS-CoV-2.
    Song S; Peng H; Wang Q; Liu Z; Dong X; Wen C; Ai C; Zhang Y; Wang Z; Zhu B
    Food Funct; 2020 Sep; 11(9):7415-7420. PubMed ID: 32966484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbicidal actives with virucidal efficacy against SARS-CoV-2.
    Ijaz MK; Whitehead K; Srinivasan V; McKinney J; Rubino JR; Ripley M; Jones C; Nims RW; Charlesworth B
    Am J Infect Control; 2020 Aug; 48(8):972-973. PubMed ID: 32461067
    [No Abstract]   [Full Text] [Related]  

  • 6. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis.
    Chu DK; Akl EA; Duda S; Solo K; Yaacoub S; Schünemann HJ;
    Lancet; 2020 Jun; 395(10242):1973-1987. PubMed ID: 32497510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronavirus Disease (COVID-19) Pandemic: A Race Against Time.
    Banerjee AK; Arora N
    Curr Top Med Chem; 2020; 20(16):1434-1437. PubMed ID: 32282303
    [No Abstract]   [Full Text] [Related]  

  • 8. Antimicrobial Nanomaterials and Coatings: Current Mechanisms and Future Perspectives to Control the Spread of Viruses Including SARS-CoV-2.
    Imani SM; Ladouceur L; Marshall T; Maclachlan R; Soleymani L; Didar TF
    ACS Nano; 2020 Oct; 14(10):12341-12369. PubMed ID: 33034443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel 2019 coronavirus: Genome structure, clinical trials, and outstanding questions.
    Jogalekar MP; Veerabathini A; Gangadaran P
    Exp Biol Med (Maywood); 2020 Jun; 245(11):964-969. PubMed ID: 32306751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protecting healthcare workers during COVID-19 pandemic with nanotechnology: A protocol for a new device from Egypt.
    Ahmed MK; Afifi M; Uskoković V
    J Infect Public Health; 2020 Sep; 13(9):1243-1246. PubMed ID: 32798183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of novel coronavirus and progress toward treatment and vaccine.
    Khan MM; Noor A; Madni A; Shafiq M
    Rev Med Virol; 2020 Jul; 30(4):e2116. PubMed ID: 32495979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Discovery Strategies for SARS-CoV-2.
    Shyr ZA; Gorshkov K; Chen CZ; Zheng W
    J Pharmacol Exp Ther; 2020 Oct; 375(1):127-138. PubMed ID: 32723801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19: Time for Post-Exposure Prophylaxis?
    Gentile I; Maraolo AE; Piscitelli P; Colao A
    Int J Environ Res Public Health; 2020 Jun; 17(11):. PubMed ID: 32512873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tracking a Vaccine and Developing Therapeutics for COVID-19.
    Gould KA
    Dimens Crit Care Nurs; 2020; 39(6):293-297. PubMed ID: 33009266
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of Wearing Masks, Hand Hygiene, and Social Distancing on Influenza, Enterovirus, and All-Cause Pneumonia During the Coronavirus Pandemic: Retrospective National Epidemiological Surveillance Study.
    Chiu NC; Chi H; Tai YL; Peng CC; Tseng CY; Chen CC; Tan BF; Lin CY
    J Med Internet Res; 2020 Aug; 22(8):e21257. PubMed ID: 32750008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19: Transmission, prevention, and potential therapeutic opportunities.
    Lotfi M; Hamblin MR; Rezaei N
    Clin Chim Acta; 2020 Sep; 508():254-266. PubMed ID: 32474009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. John-Arne Røttingen.
    Mullard A
    Nat Rev Drug Discov; 2020 May; 19(5):302-303. PubMed ID: 32286497
    [No Abstract]   [Full Text] [Related]  

  • 19. Potential Anti-COVID-19 Therapeutics that Block the Early Stage of the Viral Life Cycle: Structures, Mechanisms, and Clinical Trials.
    Al-Horani RA; Kar S; Aliter KF
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32718020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance.
    Ahn BY; Kang CK; Seo JD; Choe PG; Song SH; Park WB; Park SW; Kim NJ; Oh MD
    J Korean Med Sci; 2020 Jun; 35(24):e231. PubMed ID: 32567262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.